Thought Leadership for Life Science Leaders

Blog

Speak to Our Thought Leaders Today

John (Jack) Garvey Has Been Selected by Our Partners QbDVision to Join Their Newly Formed Board of Advisors

We are excited to announce that our CEO, Jack Garvey, has been selected by our partners QbDVision to join their newly formed board of advisors! Check out the LinkedIn excerpt below to learn more.

John (Jack) Garvey Has Been Selected by Our Partners QbDVision to Join Their Newly Formed Board of Advisors

LinkedIn Post QbDVision

Taken from LinkedIn

“At QbDVision, we firmly believe that finding the right guides is just as important as discovering the right path. We’re incredibly fortunate to have found both!

As we map the path to #DigitalCMC, we’re excited to announce that we’ll be guided by an exceptional new Board of Advisors: Joschka BuyelGloria Gadea-Lopez, John (Jack) Garvey and Rebecca Waterbury. They bring our team an incredible depth of insight on a wide range of critical aspects of the CMC process and have already made an invaluable impact on multiple areas of our product and business.

Big thanks to these remarkable leaders for the guidance and expertise they’ve already shared with our team. We couldn’t ask for a more exceptional group of advisors!”

Learn more about this visionary board and how they round out our roster

A bit more from Managing Partner Jack Garvey –

“I’m honored to have been asked to be an Advisory Board member at QbDVision! I’ve always been ‘software-neutral,’ but QbDVision has changed the game with a process-driven, data-centric approach to regulated product commercialization that is currently unmatched. What excites me though — a quality and compliance guy — #quality #compliance #fda #software #data is how QbDVision creates a knowledge map that will greatly enhance the ability to succeed in FDA and other regulatory inspections.”

Contact Us

To learn more about Jack Garvey and Compliance Architects, fill out the form below to get in contact with us!

Beyond the Signature: Reexamining Informed Consent in Clinical Research

Informed consent in clinical research is often considered a regulatory checkbox, but it...

Understanding the Impact of ICH E6 on Your GCP Quality and Compliance Program

Quality Assurance (QA) in Clinical Development has significantly changed over the past two...